Search Immortality Topics:

Page 10,990«..1020..10,98910,99010,99110,992..11,00011,010..»


28 . Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIa. Pandemic Flu NQ – Video

Posted: November 5, 2012 at 7:44 pm


28 . Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIa. Pandemic Flu NQ
An influenza pandemic is a global outbreak of disease that occurs when a new influenza A virus appears or "emerges" in the human population, causes serious illness, and then spreads easily from person to person worldwide. Is a worldwide outbreak of influenza possible? Probable is what experts would call it. Is the film Contagion science fiction? or a documentary on something that hasn #39;t happened yet? How accurate is it? How worried should we be? This lecture looks at a pandemic as a matter of time and puts current research into a biotechnology perspective.From:Albert KauschViews:0 0ratingsTime:01:10:53More inScience Technology

Read more here:
28 . Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIa. Pandemic Flu NQ - Video

Recommendation and review posted by G. Smith

29. Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIb. Bioweapons NQ – Video

Posted: November 5, 2012 at 7:44 pm


29. Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIb. Bioweapons NQ
Bioterrorism is the deliberate use of microbial agents and toxins as weapons. prior to 9/11 bioweapons were not considered a (very) serious threat, but now we realize the insidious possibility of human suicide delivery agents. Infected humans could act as dispersal genets for diseases that would otherwise be difficult to weaponize. In addition the applications of biotechnology and synthetic biology make these types of weapons cheaper and faster to manufacture that atomic weapons. This lecture review the top six most probable bioweapons and some of the possibilities for synthetic weapons in the future.From:Albert KauschViews:0 0ratingsTime:01:15:36More inScience Technology

The rest is here:
29. Medical Biotechnology:Biotechnology Applications in Tough Times. Part IIIb. Bioweapons NQ - Video

Recommendation and review posted by G. Smith

The Money Report with Dave Gentry -E03- Biotechnology – Video

Posted: November 5, 2012 at 7:44 pm


The Money Report with Dave Gentry -E03- Biotechnology
"The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The third episode features executive interviews with Galectin Therapeutics (NasdaqCM: GALT), ChromaDex Corp. (OTC BB: CDXC), NeoStem (NYSE: NBS), and Galena BioPharma (NasdaqCM: GALE). The show also features a segment on Echo Therapeutics (NasdaqCM: ECTE). Visit http://www.RedChip.com for more information.From:redchipuserViews:5 0ratingsTime:24:24More inNews Politics

See more here:
The Money Report with Dave Gentry -E03- Biotechnology - Video

Recommendation and review posted by G. Smith

Neuroscience to Neuro-patient: Melissa’s Chiari

Posted: November 5, 2012 at 7:44 pm


Neuroscience to Neuro-patient: Melissa #39;s Chiari Pseudotumor Story
Just over a year ago my life came to a screeching halt because I woke up with a headache. I had been (self) diagnosed with Chiari Malformation in 2008 and had successful decompression surgery in 2009. Two years later I was diagnosed with Pseudotumor Cerebri. I went from being an Honor #39;s student at the University of Nebraska at Omaha, majoring in neuroscience and biotechnology (with a minor in chemistry) to be a disabled, frustrated neuro-patient with more doctors than I could manage. These conditions SUCK! And the hurt! And no one knows about them!!! My life now revolves around caring for my kiddos, helping fellow chiarians, and trying to tell the world about these horrid conditions. Of course I still do as much amature, non-laboratory based research in hopes of finding a way to return to my normal abnormal life. 🙂 A cure is there, we just have to find it.From:JohnnysAngel00Views:4 2ratingsTime:05:42More inScience Technology

Original post:
Neuroscience to Neuro-patient: Melissa's Chiari

Recommendation and review posted by G. Smith

Mark Emalfarb 8 30 – Video

Posted: November 5, 2012 at 7:44 pm


Mark Emalfarb 8 30
Dyadic at the World Congress on Industrial Biotechnology Bioprocessing Mark Emalfarb - Dyadic #39;s Chief Executive Officer - April 2012From:BiuegenesViews:0 0ratingsTime:03:21More inSports

View original post here:
Mark Emalfarb 8 30 - Video

Recommendation and review posted by G. Smith

Pharma-Biotech Needs a New Financing Model or We Are Doomed! – Video

Posted: November 5, 2012 at 7:44 pm


Pharma-Biotech Needs a New Financing Model or We Are Doomed!
Duane Roth, CEO, CONNECT Webinar Date: April 27, 2011 Agenda: » What killed the fully integrated model? » Has the start-up model run its course? » What will the next model look like? » Where will future investments come from? » What role should federal and state government play? Speaker Biography: Duane J. Roth is Chief Executive Officer and Member of the Board of CONNECT. CONNECT is the globally recognized nonprofit organization dedicated to creating and sustaining the growth of innovative technology and life science businesses in San Diego. CONNECT has been directly involved with over 2000 companies since its inception in 1985 and these companies have secured over $10 billion in funding. Prior to joining CONNECT, Mr. Roth founded Alliance Pharmaceutical Corp., where he served as Chairman of the Board. Prior to Alliance, he held senior management positions at Johnson Johnson and Wyeth (now Pfizer) operating companies. He has served as a Member of the Board of Directors and executive committees of the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI) and BIOCOM (past Chair). Mr. Roth was appointed to the oversight board of the California Institute of Regenerative Medicine (CIRM) by Governor Arnold Schwarzenegger in 2006 and was elected Vice Chairman in 2009.From:ShareVaultViews:0 0ratingsTime:53:57More inEducation

Originally posted here:
Pharma-Biotech Needs a New Financing Model or We Are Doomed! - Video

Recommendation and review posted by G. Smith


Page 10,990«..1020..10,98910,99010,99110,992..11,00011,010..»